Debut Plus

14.38

+0 +0.00%

18 Jul 2026

BSE Listed

GSM 2

Adline Chem Lab Limited (524604)

Volume: 0Avg Vol 1W: 100Avg Vol 1M: 77752W Range:7.618.1
Key Ratios
Checked 5h ago
Market Cap₹8 Cr
Current Price₹14.38
Previous Close₹14.38
High / Low (52w)₹18.1 / ₹7.6
Volume0
Avg Vol (1W)100
Avg Vol (1M)777
Stock P/E
Book Value₹-3.03
Dividend Yield0%
ROE15.84%
ROA-385.71%
Revenue (TTM)
Revenue Growth
Profit Margin0%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹11.87
200 DMA₹15.54
Day change+0.00%
SurveillanceGSM 2 (as of 2026-07-17)
Price Chart
14.38 8.35% · 1Y
1886K
2025-07-17
2026-07-17

20-day avg volume: 545 shares

Pros
  • Healthy return on equity of 15.8%.
  • Company is almost debt-free.
  • Revenue grew 248800% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹8 Cr₹6 Cr₹7 Cr₹6 Cr₹1 Cr₹1 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹-4 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹-4 Cr₹-1 Cr₹1 Cr₹-4 Cr₹0 Cr₹0 Cr
EPS00.05-6.45-2.191.23-7.24-0.46-0.21
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹23 Cr₹22 Cr₹8 Cr₹6 Cr₹5 Cr₹0 Cr₹0 Cr₹0 Cr
Total Liabilities₹16 Cr₹15 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr
Equity₹7 Cr₹7 Cr₹3 Cr₹2 Cr₹3 Cr₹-2 Cr₹-1 Cr₹-1 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 25.85% Institutions 0% Public 74.15%
Efficiency & Working Capital
ROCE-495.8%
Interest Coverage-0.2
Dividend Payout
Debtor Days
Inventory Days
Payable Days
Cash Conversion Cycle
Working Capital Days
Shareholding Details

As of 2026-03-31

Promoter25.9%
FII0%
DII0%
Institutions0%
Public74.1%
Promoter Pledge0%
No. of Shareholders18,446
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters28.2%28.2%28.2%29.6%29.6%29.6%29.6%29.6%29.6%29.6%25.9%25.9%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public71.8%71.8%71.8%70.4%70.4%70.4%70.4%70.4%70.4%70.4%74.1%74.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders18,66118,63818,62818,59518,58318,53618,50918,51418,48118,48818,46818,446
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Hemant Amrish ParikhShareholding of Promoter and Promoter Group25.9%15,12,440
Sonal R BambhaniaPublic Shareholding1.1%66,600
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Hemant Amrish Parikh00%2026-03-31
Sonal R Bambhania00%2026-03-31
Hemant Amrish Parikh00%2025-12-31
Sonal R Bambhania00%2025-12-31
Hemant Amrish Parikh00%2025-09-30
Balkrishna B Patel00%2025-09-30
Jagrutiben J Laskari00%2025-09-30
Gaurav B Patel00%2025-09-30
Priyanka A Patel00%2025-09-30
Paulomi Zabal Laskari00%2025-09-30
Paulomy Lashkari00%2025-09-30
Dineshchandra Bhikhabhai Patel00%2025-09-30
Board of Directors
NameDesignationYear
Dhawal Akhilesh DeopuraIndependent Director2025
Shivani PathakIndependent Director2025
Krish PatelIndependent Director2025
Him VyasIndependent Director2025
Vrushank Balkrushna PatelChairman & Executive Director2025
Nilay Jitendrabhai VaghasiyaExecutive Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals and Nutraceuticals₹1 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10666
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000011
2025000011
2025000011
Substantial Acquisitions (SAST)

6 disclosure(s)

Off Market01/02/2024 · 14,32,040
Off Market01/02/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Company Information
Incorporated1988
ChairmanVrushank Balkrushna Patel
AuditorDeepak Soni & Associates/Jain Kedia & Sharma
Investor Email[email protected]
🌐 www.kamronlabs.com

📍 A-514 Steller Opp Arista Bldg, Sindhu bhavan Road Bodakdev, Ahmedabad, Gujarat, 380054

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search